drugset / Trial / NCT00377858

Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes (IOOX)

NCT00377858

Phase 4 Completed 484 enrolled Eli Lilly and Company
RandomizedParallel-groupOpen-labelTreatment

Summary

A study of patients with type 2 diabetes and inadequate glycemic control on two or more oral antihyperglycemic agents comparing adding insulin lispro mid mixture to the oral antihyperglycemic agents to adding insulin glargine to the oral antihyperglycemic agents.

Timeline

Start
2006-08
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Lispro Protein / enzyme biologic Subcutaneous
Comparator insulin glargine Protein / enzyme biologic Subcutaneous